Merck to Present at the 39th Annual J.P. Morgan Healthcare Conference
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Kenneth C. Frazier, chairman and chief executive officer, Robert Davis, chief financial officer, and Dr. Dean Li, president, Merck Research Laboratories, are scheduled to participate in the 39th Annual J.P. Morgan Healthcare Conference on Jan. 11, 2021 at 4:30 p.m. EST.